Changes in serum uric acid have a reciprocal effect on eGFR change: A 10-year follow-up study of community-based screening in Okinawa, Japan

Hypertension Research

Volumn 36, Issue 7, 2013, Pages 650-654

  Iseki, Kunitoshi ^a   Iseki, Chiho ^a   Kinjo, Kozen ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

CKD; eGFR; hyperuricemia; screening

Indexed keywords

CREATININE; URIC ACID;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COMMUNITY ASSESSMENT; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL SOCIETY; METABOLIC SYNDROME X; MULTIPLE REGRESSION; RISK FACTOR; URIC ACID BLOOD LEVEL;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; URIC ACID;

EID: 84881465299     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.11     Document Type: Article

References (25)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
2. Yu M, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010; 28: 1234-1242.
3. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulo-pathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
4. Sowers JR. Metabolic risk factors and renal disease. Kidney Int 2007; 71: 719-720. (Pubitemid 46624014)
5. Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 2010; 123: 957-961.
6. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systemic review and meta-analysis. Arthritis Rheum 2009; 161: 885-892.
7. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374. (Pubitemid 43323089)
8. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805. (Pubitemid 26093091)
9. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474. (Pubitemid 36350012)
10. Iseki K. The Okinawa screening program. J Am Soc Nephrol 2003; 14 (Suppl 2), S127-S130. (Pubitemid 36750507)
11. Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44: 806-814. (Pubitemid 39445912)
12. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
13. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001; 24: 691-697. (Pubitemid 33133783)
14. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor of developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-650. (Pubitemid 39237608)
15. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
16. Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, Takishita S, Iseki K. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007; 30: 937-943. (Pubitemid 350120971)
17. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B. LIFE Study GroupThe impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041-1049. (Pubitemid 38251080)
18. Athyros VG, Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Milionis HJ, Mikhailidis DPGREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004; 43: 589-599. (Pubitemid 38401873)
19. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-441. (Pubitemid 351597496)
20. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
21. Siu YP, Leung KT, Tong MKH, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59.
22. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010; 5: 1388-1393.
23. Cain L, Shankar A, Ducatman AM, Steenland K. The relationship between uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant 2010; 25: 3593-3599.
24. Whelton A, Macdonald PA, Zhao L, Hunt B. Renal function in gout: long-term treatment effects of febuxostat. J Clin Rheumatol 2011; 17: 7-13.
25. Guideline for the management of hyperuricemia and gout. Second Edition, 2010. Japanese Society of Gout and Nucleic Acid Metabolism.